[PDF] Top 20 <p>Rituximab-based combination therapy in patients with Waldenstr&ouml;m macroglobulinemia: a systematic review and meta-analysis</p>

... for patients with a high serum IgM level or a heavy tumor burden. Rituximab is the backbone of the treatment when used in combination with other agents such as proteasome inhibitors, immu- ... See full document

... SLE patients, especially among those who were on ...HCQ therapy had a significantly statistical association with serum lipids reduction in SLE ...lupus patients in ...a systematic review ... See full document

... A systematic review of 4 randomized controlled trials and 8 retrospective trials comparing SC to intravenous (IV) bortezomib among 1,857 MM patients was ...events meta-analyses were performed. ... See full document

... In recent years, some retro- spective data have suggested a possible role for cytoreduc- tive prostatectomy in patients with mPCa. However, such an approach has not been rigor- ously evaluated, with contro- ... See full document

... but combination therapy with UDCA could improve liver biochemistry indicators such as ALP, gamma-glutamyltransferase, immunoglobulin M, total cholesterol, bilirubin, ALT, and triglycerides in PBC ... See full document

... Several limitations may affect the result of the present study. First, the pooled RR for overall response in indo- lent ML may be overestimated as a result of publication bias. In fact, smaller studies suggest a more ... See full document

... the meta-analysis results, with I 2 values of 0%, 25%, 50%, and 75% representing no, low, moderate, and high heterogene- ity, ...respectively. Based on the Cochrane review guidelines, 24 a ... See full document

... the analysis, which showed a consistent trend with the overall ...of meta-analysis, the heterogeneity of muscle strength and lung function among studies was still ...be based on information ... See full document

... The authors believe that due to the multifactorial etiology of delirium, multicomponent, perioperative and multidisciplin- ary interventions should be implemented to prevent patients from developing delirium. In ... See full document

... Studies that assessed the effect of kiwifruit on metabolic health in patients with cardiovascular risk factors were selected. Lit- erature search was conducted from the respective inception until August 2018 ... See full document

... this analysis, some limitations have been ...of patients and patient ...a combination of various complicated factors, including a variety of genetic ... See full document

... for meta-analysis unless otherwise ...of patients, age, gender, tumor size, mor- tality, morbidity, operation time, blood loss, blood transfu- sion, hospital stay, reoperation and long term survival ... See full document

... the analysis using ADAS-Cog and QoL, and therefore the outcome assess- ments of our review were MMSE and ...NPI. Based on our research, we have supplemented the evidence that CST combined with drugs ... See full document

... We will include studies of all adults (i.e., ≥18 years old) with chronic pain conditions in both treatment and control participants. We will adopt the definition of pain provided by the International Association for the ... See full document

... CHB patients with LAM resistance, and (3) intervention therapies con- sisting of LAM plus ADV versus ETV ...monotherapy. Patients were excluded if they (1) were not adults, (2) were pregnant, (3) infected ... See full document

... Despite these encouraging results, many unsolved questions remain regarding targeted therapies combined with CT in TNBC patients. There are still no answers for some important points: which is the most suitable ... See full document

... In view of quantifying the systematic review, three meta-analyses were performed. The results show a positive association between stroke and the presence of periodonti- tis, with a risk of 2.31 (95% ... See full document

... This systematic review has several ...our review, and most of the studies had a relatively small sample ...the patients after treatment and reported adverse events; thus, studies with more ... See full document

... This systematic review, with meta-analysis, will provide a comprehensive systematic analysis of clinical studies that have examined the effects of systematic testosterone ... See full document

... subset analysis of a Phase III, open-label trial by Rummel et al, comparing bendamustine in combination with ritux- imab (BR) with rituximab, cyclophosphamide, doxorubicin, vincristine, and ... See full document